메뉴 건너뛰기




Volumn 73, Issue 2, 2015, Pages 310-311

The new US Food and Drug Administration pregnancy and lactation labeling rules: Their impact on clinical practice

Author keywords

[No Author keywords available]

Indexed keywords

NON PRESCRIPTION DRUG;

EID: 84937402227     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2015.04.026     Document Type: Editorial
Times cited : (6)

References (8)
  • 1
    • 84922324359 scopus 로고    scopus 로고
    • Content and format of labeling for human prescription drug and biological products; Requirements for pregnancy and lactation labeling. Final rule
    • Food and Drug Administration, HHS Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule Fed Regist 79 2014 72063 72103
    • (2014) Fed Regist , vol.79 , pp. 72063-72103
  • 2
    • 0033821938 scopus 로고    scopus 로고
    • Risk classification systems for drug use during pregnancy: Are they a reliable source of information?
    • A. Addis, S. Sharabi, and M. Bonati Risk classification systems for drug use during pregnancy: are they a reliable source of information? Drug Saf 23 2000 245 253
    • (2000) Drug Saf , vol.23 , pp. 245-253
    • Addis, A.1    Sharabi, S.2    Bonati, M.3
  • 3
    • 0034756895 scopus 로고    scopus 로고
    • FDA labeling system for drugs in pregnancy
    • L.A. Boothby, and P.L. Doering FDA labeling system for drugs in pregnancy Ann Pharmacother 35 2001 1485 1489
    • (2001) Ann Pharmacother , vol.35 , pp. 1485-1489
    • Boothby, L.A.1    Doering, P.L.2
  • 4
    • 0036677663 scopus 로고    scopus 로고
    • Review of pregnancy labeling of prescription drugs: Is the current system adequate to inform of risks?
    • P.L. Doering, L.A. Boothby, and M. Cheok Review of pregnancy labeling of prescription drugs: is the current system adequate to inform of risks? Am J Obstet Gynecol 187 2002 333 339
    • (2002) Am J Obstet Gynecol , vol.187 , pp. 333-339
    • Doering, P.L.1    Boothby, L.A.2    Cheok, M.3
  • 6
    • 84947607607 scopus 로고    scopus 로고
    • Evaluating the impact of FDA's pregnancy and lactation labeling rule
    • December 16, 2014. Available at:. Accessed March 25
    • Chambers CD. Evaluating the impact of FDA's pregnancy and lactation labeling rule. Dermatology News. December 16, 2014. Available at: http://www.edermatologynews.com/views/single-view/evaluating-the-impact-of-fdas-pregnancy-and-lactation-labeling-rule/0c73d9cc718200951776403b0a9d8760.html. Accessed March 25, 2015.
    • (2015) Dermatology News
    • Chambers, C.D.1
  • 7
    • 84937443169 scopus 로고    scopus 로고
    • US Food and Drug Administration website Published May 20, 1999. Available at:. Accessed March 25
    • US Food and Drug Administration website. Summary of comments from a public hearing and model pregnancy labeling based on recommendations. Published May 20, 1999. Available at: http://www.fda.gov.ucsf.idm.oclc.org/ohrms/dockets/ac/99/transcpt/3516r1.doc. Accessed March 25, 2015.
    • (2015) Summary of Comments from A Public Hearing and Model Pregnancy Labeling Based on Recommendations
  • 8
    • 58849089025 scopus 로고    scopus 로고
    • Probability information in risk communication: A review of the research literature
    • V.H. Visschers, R.M. Meertens, W.W. Passchier, and N.N. de Vries Probability information in risk communication: a review of the research literature Risk Anal 29 2009 267 287
    • (2009) Risk Anal , vol.29 , pp. 267-287
    • Visschers, V.H.1    Meertens, R.M.2    Passchier, W.W.3    De Vries, N.N.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.